LP04 : A Phase 3, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of 12 Weeks of Simeprevir (SMV) Plus Sofosbuvir (SOF) in Treatment-Naïve or -Experienced Patients with Chronic HCV Genotype 1 Infection and Cirrhosis: Optimist-2
JOURNAL OF HEPATOLOGY（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要